FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2983060618> ?p ?o ?g. }

• W2983060618 endingPage "2370" @default.
• W2983060618 startingPage "2359" @default.
• W2983060618 abstract "The aim of this study was to investigate the optimal strategy for antiplatelet therapy in patients with lower extremity peripheral artery disease (PAD) after endovascular revascularization.The optimal strategy for antiplatelet therapy in patients with PAD after endovascular revascularization has not been established.From March 2008 to February 2013, 693 patients with lower extremity PAD treated with different antiplatelet therapies, such as mono-antiplatelet therapy (MAPT) and dual-antiplatelet therapy (DAPT), of various durations after endovascular revascularization were analyzed. They were classified into 2 groups (DAPT <6 months or MAPT vs. DAPT ≥6 months). The primary outcomes were major adverse cardiovascular events and major adverse limb events. The safety outcome was major bleeding.During 5-year follow-up, major adverse cardiovascular events occurred less frequently in the DAPT ≥6-month group than the DAPT <6-month or MAPT group (17.3% vs. 31.3%; hazard ratio: 0.44; 95% confidence interval: 0.30 to 0.65; p < 0.001). Major adverse limb events also occurred less frequently in the DAPT ≥6-month group than the DAPT <6-month or MAPT group (21.5% vs. 43.7%; hazard ratio: 0.42; 95% CI: 0.30 to 0.58; p < 0.001). However, major bleeding events were infrequent, with no signal toward harm with DAPT ≥6 months. Results were consistent after inverse probability-weighted adjustment and propensity score matching.Following endovascular revascularization for lower extremity PAD, DAPT ≥6 months was associated with decreased 5-year major adverse cardiovascular events and major adverse limb events." @default.
• W2983060618 created "2019-11-22" @default.
• W2983060618 creator A5004789784 @default.
• W2983060618 creator A5008942832 @default.
• W2983060618 creator A5015897790 @default.
• W2983060618 creator A5022383639 @default.
• W2983060618 creator A5035099745 @default.
• W2983060618 creator A5060843061 @default.
• W2983060618 creator A5069722745 @default.
• W2983060618 creator A5079801328 @default.
• W2983060618 creator A5080970990 @default.
• W2983060618 creator A5081321839 @default.
• W2983060618 creator A5081680751 @default.
• W2983060618 creator A5086178193 @default.
• W2983060618 date "2019-12-01" @default.
• W2983060618 modified "2023-10-01" @default.
• W2983060618 title "Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease" @default.
• W2983060618 cites W1596397105 @default.
• W2983060618 cites W1979084017 @default.
• W2983060618 cites W1979927175 @default.
• W2983060618 cites W1990802090 @default.
• W2983060618 cites W2008836245 @default.
• W2983060618 cites W2033924621 @default.
• W2983060618 cites W2037500444 @default.
• W2983060618 cites W2087150869 @default.
• W2983060618 cites W2098364806 @default.
• W2983060618 cites W2099489133 @default.
• W2983060618 cites W2110818436 @default.
• W2983060618 cites W2111984022 @default.
• W2983060618 cites W2144985796 @default.
• W2983060618 cites W2148374679 @default.
• W2983060618 cites W2175608702 @default.
• W2983060618 cites W2205938495 @default.
• W2983060618 cites W2295484744 @default.
• W2983060618 cites W2315630371 @default.
• W2983060618 cites W2556838984 @default.
• W2983060618 cites W2804382481 @default.
• W2983060618 cites W2811185415 @default.
• W2983060618 cites W2890731622 @default.
• W2983060618 cites W2910601010 @default.
• W2983060618 cites W2975859535 @default.
• W2983060618 cites W4292856638 @default.
• W2983060618 cites W76788954 @default.
• W2983060618 doi "https://doi.org/10.1016/j.jcin.2019.08.006" @default.
• W2983060618 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31734299" @default.
• W2983060618 hasPublicationYear "2019" @default.
• W2983060618 type Work @default.
• W2983060618 sameAs 2983060618 @default.
• W2983060618 citedByCount "25" @default.
• W2983060618 countsByYear W29830606182019 @default.
• W2983060618 countsByYear W29830606182020 @default.
• W2983060618 countsByYear W29830606182021 @default.
• W2983060618 countsByYear W29830606182022 @default.
• W2983060618 countsByYear W29830606182023 @default.
• W2983060618 crossrefType "journal-article" @default.
• W2983060618 hasAuthorship W2983060618A5004789784 @default.
• W2983060618 hasAuthorship W2983060618A5008942832 @default.
• W2983060618 hasAuthorship W2983060618A5015897790 @default.
• W2983060618 hasAuthorship W2983060618A5022383639 @default.
• W2983060618 hasAuthorship W2983060618A5035099745 @default.
• W2983060618 hasAuthorship W2983060618A5060843061 @default.
• W2983060618 hasAuthorship W2983060618A5069722745 @default.
• W2983060618 hasAuthorship W2983060618A5079801328 @default.
• W2983060618 hasAuthorship W2983060618A5080970990 @default.
• W2983060618 hasAuthorship W2983060618A5081321839 @default.
• W2983060618 hasAuthorship W2983060618A5081680751 @default.
• W2983060618 hasAuthorship W2983060618A5086178193 @default.
• W2983060618 hasBestOaLocation W29830606181 @default.
• W2983060618 hasConcept C126322002 @default.
• W2983060618 hasConcept C141071460 @default.
• W2983060618 hasConcept C164705383 @default.
• W2983060618 hasConcept C197934379 @default.
• W2983060618 hasConcept C207103383 @default.
• W2983060618 hasConcept C2779464278 @default.
• W2983060618 hasConcept C44249647 @default.
• W2983060618 hasConcept C500558357 @default.
• W2983060618 hasConcept C71924100 @default.
• W2983060618 hasConceptScore W2983060618C126322002 @default.
• W2983060618 hasConceptScore W2983060618C141071460 @default.
• W2983060618 hasConceptScore W2983060618C164705383 @default.
• W2983060618 hasConceptScore W2983060618C197934379 @default.
• W2983060618 hasConceptScore W2983060618C207103383 @default.
• W2983060618 hasConceptScore W2983060618C2779464278 @default.
• W2983060618 hasConceptScore W2983060618C44249647 @default.
• W2983060618 hasConceptScore W2983060618C500558357 @default.
• W2983060618 hasConceptScore W2983060618C71924100 @default.
• W2983060618 hasIssue "23" @default.
• W2983060618 hasLocation W29830606181 @default.
• W2983060618 hasLocation W29830606182 @default.
• W2983060618 hasOpenAccess W2983060618 @default.
• W2983060618 hasPrimaryLocation W29830606181 @default.
• W2983060618 hasRelatedWork W1973268331 @default.
• W2983060618 hasRelatedWork W2003938723 @default.
• W2983060618 hasRelatedWork W2047967234 @default.
• W2983060618 hasRelatedWork W2050182103 @default.
• W2983060618 hasRelatedWork W2086010554 @default.
• W2983060618 hasRelatedWork W2118496982 @default.
• W2983060618 hasRelatedWork W2364998975 @default.

• next